Search Results « 1 2 3 4 5 » Page 1 of 38 | Results 1 - 10 of 371 Mifepristone may halt growth of intracranial tumor that causes hearing loss April 03, 2018 A Mass. Eye and Ear team has identified mifepristone, an FDA-approved drug for chemical abortion,... Massachusetts Eye and Ear Joins Partners HealthCare April 02, 2018 Partners HealthCare announced today that Massachusetts Eye and Ear, a specialty teaching hospital... Researchers develop new class of antibiotics to fight leading superbugs March 29, 2018 In a significant advance against drug-resistant superbugs, investigators have identified a new... Mass. Eye and Ear performs first FDA-approved gene therapy procedure for inherited disease March 20, 2018 Massachusetts Eye and Ear made medical history on Tuesday by performing the first post-FDA... Scientists, Advocates Team Up to Launch Odylia Therapeutics to Accelerate Gene Therapy Trials for Rare Conditions Causing Blindness February 28, 2018 New nonprofit organization will bring treatments to clinical trial for people at risk for... Team Eye and Ear kicks off 2018 Boston Marathon training February 23, 2018 Through a partnership with John Hancock Financial Services, Massachusetts Eye and Ear is... Janey L. Wiggs, M.D., Ph.D., FARVO, receives ARVO Dr. David L. Epstein Award February 08, 2018 Prestigious award honors commitment to glaucoma research David A. Solá-Del Valle, M.D., joins Mass. Eye and Ear Glaucoma Service February 05, 2018 CRISPR therapy preserves hearing in progressive deafness model December 20, 2017 Researchers deliver CRISPR-Cas9 directly into the inner ear hair cells of mice, preventing... Invasive cells in head and neck tumors predict cancer spread November 30, 2017 Cutting edge technology applied to head and neck tumors reveals a unique transition that is... « 1 2 3 4 5 » Page 1 of 38 | Results 1 - 10 of 371